Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.

By N. Breet, J. V. van Werkum, H. Bouman, J. Kelder, H. Ruven, E. Bal, V. Deneer, A. Harmsze, J. Van der Heyden, B. Rensing and 3 more. Journal of the American Medical Association (JAMA), 2010

866 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/74f68de1fbffb99c58af736ad7ca45577c007e5c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Bonello
2. U. Tantry
3. M. Price
4. D. Angiolillo
5. Deepak L. Bhatt
6. R. Marcucci
7. Gregg Stone
8. J. V. van Werkum

Citations in the corpus

• 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. (2011, background): “Nonetheless, pointof-care tests that indicate normal platelet ADP responsiveness after administration of a loading dose of clopidogrel suggest P2Y12 resistance with as much as 85% specificity [32, 34].”
• Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. (2010, methodology): “Similarly, following hese findings, 2 other studies (82,91) have suggested that the elective administration of platelet GP IIb/IIIa receptor blockethods Definition Clinical Relevance”
• Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. (2013, background): “Recently, the prospective TARGET-CABG (Time Based Strategy to Reduce Clopidogrel Associated Bleeding During CABG) study demonstrated that stratifying clopidogrel-treated patients on background aspirin therapy to specific waiting periods based on a pre-operative assessment of clopidogrel response res”